{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Stepan Co. Stock Plummets to New 52-Week Low at $43.15
Stepan Co., a small-cap specialty chemicals company, has reached a new 52-week low, reflecting a challenging year with a significant performance decline. The company has a market capitalization of USD 1,349 million, a P/E ratio of 26.00, and has struggled with operational profitability and cash flow issues.
Stepan Co. Experiences Revision in Its Stock Evaluation Amidst Market Challenges
Stepan Co., a small-cap specialty chemicals firm, has adjusted its valuation amid a challenging year, posting a -36.73% return compared to the S&P 500's gain. Key metrics include a P/E ratio of 26 and a dividend yield of 2.32%, indicating areas for potential improvement in a competitive market.
Is Stepan Co. overvalued or undervalued?
As of October 24, 2025, Stepan Co. is considered overvalued with a fair valuation grade, reflected by its high P/E ratio of 26 compared to peers and a significant year-to-date return lag of -28.69% versus the S&P 500's 15.47%.
Stepan Co. Experiences Evaluation Adjustment Amidst Competitive Specialty Chemicals Landscape
Stepan Co., a small-cap specialty chemicals firm, has adjusted its valuation metrics, including a P/E ratio of 26 and a PEG ratio of 2.53. Despite facing performance challenges with a year-to-date return of -29.49%, the company remains competitive within its sector, contrasting with the S&P 500's positive performance.
Stepan Co. Experiences Valuation Adjustment Amidst Competitive Specialty Chemicals Landscape
Stepan Co., a small-cap specialty chemicals firm, has recently adjusted its valuation, with its stock price at $47.20. Over the past year, the company has faced challenges, posting a return of -35.97%. Key financial metrics include a P/E ratio of 26 and a dividend yield of 2.32%.
Is Stepan Co. technically bullish or bearish?
As of September 2, 2025, Stepan Co. is in a bearish trend confirmed by multiple indicators, underperforming the S&P 500 with a year-to-date return of -22.87% compared to the S&P 500's 12.22%.
Is Stepan Co. overvalued or undervalued?
As of September 11, 2025, Stepan Co. is considered undervalued in the specialty chemicals sector with an attractive valuation grade, despite a year-to-date return of -22.87% and a higher EV to EBITDA ratio of 10.60 compared to its peers.
Is Stepan Co. technically bullish or bearish?
As of May 8, 2025, the trend is mildly bearish due to daily moving averages and monthly indicators signaling bearishness, despite some mildly bullish weekly signals and mixed RSI readings.
Is Stepan Co. overvalued or undervalued?
As of June 13, 2025, Stepan Co. is considered very attractive and undervalued, with a P/E ratio of 26, an EV to EBITDA ratio of 10.60, and key ratios indicating potential upside despite recent underperformance against the S&P 500.
Who are in the management team of Stepan Co.?
As of March 2022, the management team of Stepan Co. includes Chairman and CEO Frank Stepan, Lead Independent Director Edward Wehmer, and Independent Directors Michael Boyce, Randall Dearth, Joaquin Delgado, and Gregory Lawton, who oversee the company's strategic direction and governance.
What does Stepan Co. do?
Stepan Co. is a small-cap company that produces specialty and intermediate chemicals, with recent net sales of $593 million and a net profit of $20 million. Key metrics include a P/E ratio of 26.00, a dividend yield of 2.35%, and a market cap of $1.46 billion.
How big is Stepan Co.?
As of Jun 18, Stepan Co. has a market capitalization of 1,455.20 million, with net sales of 2,222.10 million and a net profit of 56.19 million over the latest four quarters. The company reported shareholder's funds of 1,169.93 million and total assets of 2,304.65 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
